PLK1: A Promising and Previously Unexplored Target in Double-Hit Lymphoma

Journal of Clinical Investigation - United States
doi 10.1172/jci124919
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Double‐hit Lymphoma: So What?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Double Hit and Double Expressors in Lymphoma: Definition and Treatment

Cancer
Cancer ResearchOncology
2018English

Drug Therapy for Double-Hit Lymphoma

Drugs in Context
Molecular MedicinePharmacology
2019English

­­The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2011English

Flaviviruses Hit a Moving Target

Cell
BiochemistryGeneticsMolecular Biology
2018English

Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Overexpression of FoxM1 Offers a Promising Therapeutic Target in Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2012English

“Triple-Triple” Hit Lymphoma

Case Reports in Internal Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy